We also genetically manipulated the level of LEPRE1 expression in leukemia and lung cancer cells and revealed that LEPRE1 overexpression led to increased pelitinib sensitivity via AKT activation and overexpression of ATP-binding cassette superfamily G member 2 (ABCG2). The gene discussed is ABCG2; the disease is lung carcinoma.